Showing 7021-7030 of 8871 results for "".
- Report: Global Skin Cancer Treatment Market to Hit $14.5 Billion by 2031https://practicaldermatology.com/news/global-skin-cancer-treatment-market-poised-rapid-growth-expected-hit-145-billion-2031/2468065/A recent report from Allied Analytics said the global skin cancer treatment market is projected to nearly double, reaching $14.5 billion by 2031, driven by an increasing incidence of skin cancer and advancements in treatment options. The $7.2 billion (2021) treatment market, according to t
- Eczema Patients at Higher Risk for Comorbidities, Study Findshttps://practicaldermatology.com/news/eczema-patients-higher-risk-comorbidities-study-finds/2468064/Recent analysis of data from the NIH’s All of Us Research Program reveals significant associations between atopic dermatitis (AD) and other health conditions, underscoring the multifaceted burdens faced by AD patients. The All of Us Research Program, which collected health data from over 8
- Review: No Safety Concerns for Live Vaccines with Dupilumabhttps://practicaldermatology.com/news/systematic-review-no-safety-concerns-live-vaccines-dupilumab/2467944/Live vaccines are likely safe and effective for patients undergoing dupilumab treatment, according to results from a systematic review and expert consensus. Authors for a new systematic review, combined with expert input from a Delphi panel, provided insights into the safety and efficacy o
- Timber Pharmaceuticals Fails Phase 3 Trial for Congenital Ichthyosis Drug Candidatehttps://practicaldermatology.com/news/timber-pharmaceuticals-fails-phase-3-trial-congenital-ichthyosis-drug-candidate/2467911/LEO Pharma's subsidiary, Timber Pharmaceuticals, failed a late-stage trial for its investigational topical ointment formulation of isotretinoin for treating moderate to severe congenital ichthyosis. The phase 3 ASCEND trial was 12-week randomized, double-blind clinical study evaluating TM
- Quitting Smoking Reduces Hidradenitis Suppurativa Riskhttps://practicaldermatology.com/news/quitting-smoking-reduces-hidradenitis-suppurativa-risk/2467901/A new study suggests that smoking cessation is associated with reduced risk of developing hidradenitis suppurativa (HS). Researchers for the population-based cohort study looked at the relationship between the change in smoking habits and the incidence of HS in more than 6 million partic
- Topical Skin Introduces Hydrating Facial Cleanserhttps://practicaldermatology.com/news/topical-skin-introduces-hydrating-facial-cleanser/2467858/Topical Skin announced the launch of the Hydrating Facial Cleanser, formulated with ceramide, botanicals, and oleosomes and designed to provide a gentle yet effective cleanse while supporting the skin's barrier, resulting in a hydrated and refreshed complexion. Unlike some cleansers that
- Genome-Wide Study Reveals Genetic Correlation Between Melanoma Subtypeshttps://practicaldermatology.com/news/genome-wide-study-reveals-genetic-correlation-between-melanoma-subtypes/2467851/Data from a recent genome-wide association study (GWAS) looking at the genetic underpinnings of in situ and invasive melanoma show significant shared genetic architecture between the two. Researchers for the study used data from four population-based genetic cohorts, including the UK Bio
- Study: LTX-315 Shows 86% Reduction in BCC Tumor Sizehttps://practicaldermatology.com/news/study-ltx-315-shows-86-reduction-bcc-tumor-size/2467796/Lytix Biopharma has announced promising preliminary results from a phase 2 clinical trial evaluating the efficacy of LTX-315, its candidate drug for the treatment of basal cell carcinoma (BCC). The trial was conducted by Verrica Pharmaceuticals, according to a news release, and the result
- Tildrakizumab Shows Efficacy in Plaque Psoriasishttps://practicaldermatology.com/news/tildrakizumab-shows-significant-efficacy-plaque-psoriasis/2467713/Tildrakizumab was associated with improvements in disease severity in patients with moderate-to-severe plaque psoriasis, according to results from a new study in the Journal of Drugs in Dermatology. Researchers for the phase 4, multicenter, uncontrolled, open-label trial enrolle
- Study: Vegan Nutraceutical Improves Hair Health in Plant-Based Dietershttps://practicaldermatology.com/news/study-vegan-nutraceutical-improves-hair-health-plant-based-dieters/2467690/A recent clinical study suggested that a novel vegan nutraceutical supported hair health in women following plant-based diets. Seeking to address the nutrient deficiencies that can affect hair growth and quality in this population, researchers for the single-blind prospective study conduc